Back to today’s briefing

Story perspectives

Home-Based Mitomycin Offers Hope for Bladder Cancer

7/29/2025

48 10

Summary

Story summary

A groundbreaking phase 3b study in *Reviews in Urology* reveals that home-based mitomycin instillation offers a promising solution for recurrent low-grade, intermediate-risk non-muscle-invasive bladder cancer. Boasting a 75% completion rate and enthusiastic patient responses, this innovative treatment could significantly reduce patient burdens and enhance access to vital care, paving the way for further exploration.

1 of 1

Story summary

A groundbreaking phase 3b study in *Reviews in Urology* reveals that home-based mitomycin instillation offers a promising solution for recurrent low-grade, intermediate-risk non-muscle-invasive bladder cancer. Boasting a 75% completion rate and enthusiastic patient responses, this innovative treatment could significantly reduce patient burdens and enhance access to vital care, paving the way for further exploration.